<DOC>
	<DOCNO>NCT00628862</DOCNO>
	<brief_summary>The purpose study show efficacy safety formoterol maintenance treatment patient COPD compare placebo patient Japan European country 12 week .</brief_summary>
	<brief_title>Evaluation Efficacy Safety Formoterol Patients With COPD Compared With Placebo Patients Japan , EU</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<criteria>Males female age 40 clinical diagnosis COPD current COPD symptom Current previous smoker smoke history 10 pack year Lung function parameter : FEV1/FVC &lt; 70 % , postbronchodilator postbronchodilator FEV1 &lt; 80 % predict normal value History and/or current clinical diagnosis asthma atopic diseases allergic rhinitis Use inhale glucocorticosteroids within 4 week prior Visit 2 Any relevant cardiovascular disorder judge investigator current respiratory tract disorder COPD .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Chronic Obstructive Pulmonary Disease</keyword>
	<keyword>COPD</keyword>
</DOC>